Short description
Diasome Pharmaceuticals is a clinical-stage diabetes therapeutics company that designs and develops insulin-based therapies.
Description
Diasome Pharmaceuticals is a clinical stage diabetes therapeutics company that designs and develops insulin-based therapies. The company’s products include Oral HVD-I, a targeted oral insulin in a pill or gel cap dose form; HDV-I, an injectable short acting insulin; and HDV-B, an injectable basal long acting insulin. It develops products for patients suffering from Type 1 and Type 2 diabetes.
Diasome Pharmaceuticals was founded in 2004 and is based in Conshohocken, Pennsylvania.
Total funding
$$2020202
Sign in for full access
Location
Cleveland, Ohio, United States, North America
Founded on
January 1, 2004
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$7890 - 12340
Sign in for full access
Investors
No Way, Cannot Access, Blurry Noaccess, Noaccess, No Way, Cannot Access
Sign in for full access
Founders
Robert Geho, W. Blair Geho